Octave Specialty Group (OSG) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
8 Jul, 2026Executive summary
Total P&C premium production surged 70% to $318 million, driven by the Beat Capital acquisition and strong growth in Insurance Distribution and Specialty P&C segments.
Total revenue from continuing operations rose 27% year-over-year to $63 million, mainly due to the Beat Acquisition.
Beat Acquisition contributed over $20 million in revenue, growing 40% from Q1 2024; Serata/Cirrata generated $230–$231 million in premium, up 156%.
Net loss attributable to shareholders was $(46) million, compared to net income of $20 million in the prior year, impacted by discontinued operations and higher expenses.
All pre-closing conditions for the Legacy/AAC sale were completed, with regulatory approval pending.
Financial highlights
Adjusted EBITDA from continuing operations was a $1 million loss, compared to a slight profit in Q1 2024.
Insurance Distribution/Cirrata revenue increased 129% to $41 million; Adjusted EBITDA to shareholders was $7.1 million (17.3% margin), up 69% year-over-year.
Specialty P&C Insurance gross premiums written declined 10% to $87 million; net premiums written fell 31% to $18 million.
Consolidated net loss from continuing operations was $(16) million ($0.58/share), up from $(4) million in Q1 2024.
Total expenses increased to $78 million from $53 million, driven by higher G&A, Beat-related costs, amortization, and interest expense.
Outlook and guidance
Management targets 2028 adjusted EBITDA of $80–$90 million, up from $18 million in 2024, driven by organic growth, acquisitions, and Everspan contribution.
Focus remains on scaling specialty P&C business, with liability (casualty) lines as the main growth driver and continued diversification across property and A&H lines.
The sale of the Legacy/AAC business is expected to close by July 2025, with proceeds to be used for debt repayment and potential reinvestment.
Latest events from Octave Specialty Group
- Director elections, strategic transformation, and AI-driven growth initiatives were key highlights.OSG
AGM 20266 Jun 2026 - Transformation completed, compensation aligned, and Board urges support for all proxy proposals.OSG
Proxy filing14 May 2026 - Insurance Distribution revenue up 92%, total revenue up 66%, and adjusted EBITDA surged.OSG
Q1 20267 May 2026 - Shareholders to vote on board, compensation, auditor, and new incentive plan after major transformation.OSG
Proxy filing10 Apr 2026 - Board recommends approval of all annual meeting proposals, including director elections and compensation.OSG
Proxy filing10 Apr 2026 - Q4 2025 delivered strong premium and revenue growth, but net loss rose on acquisition costs.OSG
Q4 202524 Feb 2026 - AAC sale and Beat acquisition accelerate specialty P&C transformation and capital redeployment.OSG
Q2 20242 Feb 2026 - Legacy business sold to Oaktree and 60% of Beat acquired, accelerating specialty P&C focus.OSG
Investor Update31 Jan 2026 - Q3 net loss, 86% P&C premium growth, Beat acquisition, $50M buyback, legacy sale approved.OSG
Q3 202414 Jan 2026